Key result
Positron emission tomography (PET) is being explored for its potential clinical role in evaluating arrhythmias in patients with acute and chronic nongranulomatous myocarditis.
Why the study?
Does 18F-FDG PET imaging improve risk stratification and management in patients with nongranulomatous myocarditis?
Does 18F-FDG PET imaging improve risk stratification and management in patients with nongranulomatous myocarditis?
Answers are grounded in this paper and cite their sources.
18F-FDG PET imaging shows promise as a complementary tool to CMR for detecting active inflammation in nongranulomatous myocarditis, which could guide immune-modulatory therapy, ablation timing, and return-to-play decisions.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pelletier‐Galarneau et al. (2024) studied this question. Positron emission tomography (PET) is being explored for its potential clinical role in evaluating arrhythmias in patients with acute and chronic nongranulomatous myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: